David Southwell

Chief Executive Officer & Director at TScan Therapeutics, Inc.

David Southwell

David Southwell

Chief Executive Officer & Director at TScan Therapeutics, Inc.

Overview
Career Highlights

Human Genome Sciences, Inc.
Sunovion Pharmaceuticals, Inc.
Bionevia Pharmaceuticals, Inc.

RelSci Relationships

1051

Number of Boards

16

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals David Southwell likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Bionevia Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Rocket Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Director at First Eagle Alternative Credit LLC

Relationship likelihood: Strong

Chief Executive Officer at Associates Corp. of North America

Relationship likelihood: Strong

Managing Partner & Chief Executive Officer, Middle Market Credit at Kayne Anderson Capital Advisors LP

Relationship likelihood: Strong

Former Interim President at Avid Technology, Inc.

Relationship likelihood: Strong

Former Chair & Director at Community Capital Management, Inc.

Relationship likelihood: Strong

Co-Founder at Income Research & Management, Inc.

Relationship likelihood: Strong

Founder at PTC Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at PTC Therapeutics, Inc.

Relationship likelihood: Strong

Paths to David Southwell
Potential Connections via
Relationship Science
You
David Southwell
Chief Executive Officer & Director at TScan Therapeutics, Inc.
Education
BA

Rice University is a comprehensive research university that fosters diversity and an intellectual environment that produces the next generation of leaders and advances tomorrow’s thinking and is set in the heart of Houston, Texas, the nation’s fourth-largest city.

MBA Unknown

The Tuck School of Business at Dartmouth is the graduate business school of Dartmouth College in Hanover, New Hampshire, in the United States. Tuck is one of six Ivy league business schools. Founded in 1900, Tuck was the first institution to offer a master's degree in the field of business administration

Career History
Chief Executive Officer & Director
2018 - Current

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Director
2014 - Current

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm's clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded in 1999 and is headquartered in New York, NY.

President & Chief Executive Officer
2014 - 2018

Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA.

Boards & Committees
Director
Current

Panel Intelligence LLC is a private company headquartered in Cambridge, MA. The firm offers a powerful online health care and medical research platform providing clients greater strategic direction for investment decisions, product development, and marketing. William J. Febbo has been the CEO since 2009. On 30 Jan 09 Panel Intelligence LLC acquired Panel Intelligence LLC from Merriman Holdings, Inc. for $1.10 million.

Member, Board of Directors
Prior - 2016

THL Credit Group(THL) invests primarily US lower middle market in a variety of securities in leveraged finance, structured credit and minority equity transactions. The firm provides capital to both public and private companies for growth, recapitalizations, LBOs and acquisitions. The firm targets companies with EBITDA of $5-50 million with transaction size $75-250 million. The firm usually structures their investments as credit and equity including leveraged loans, mezzanine debt, public and private high-yield bonds, structured equity, senior loans, structured credit and minority co-investments.

Chief Financial Officer, Director & Executive Vice President
2008 - 2012

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Member, Board of Overseers
Current

The Tuck School of Business at Dartmouth is the graduate business school of Dartmouth College in Hanover, New Hampshire, in the United States. Tuck is one of six Ivy league business schools. Founded in 1900, Tuck was the first institution to offer a master's degree in the field of business administration

Political Donations
$2,400
2010

Senator from Ohio

$2,300
2007

Representative from Massachusetts's 2nd Congressional District

$500
2004

President at Milken Institute - Center for Advancing the American Dream

Transactions
Details Hidden

TScan Therapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Southwell. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Southwell's profile does not indicate a business or promotional relationship of any kind between RelSci and David Southwell.